Acetylsalicylic acid Completed Phase 4 Trials for Coronary Artery Disease / Platelet Aggregation / Platelet Transcriptome Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01815008Pharmacogenomics of Antiplatelet Response - I